Brief: BioArctic Q2 Operating Profit SEK -6.5 Million
26/08/2026 07:01
BRIEF-BioArctic Q2 Operating Profit SEK -6.5 Million Aug 26 (Reuters) - BioArctic Q2 adjusted EPS SEK -0.13.
- Q2 revenue SEK 247.5 million
- Q2 adjusted free cash flow SEK 137.8 million
- Q2 net income SEK -11.2 million
Recent news on BioArctic AB (publ)
See all newsBrief: BioArctic Gets Leqembi Pen Subcutaneous Formulation Approval In Japan
Brief: BioArctic Says Leqembi Subcutaneous Formulation Approved For Initiation Treatment In China
Brief: BioArctic Says Canada's Drug Agency Issues Final Positive Recommendation Supporting Public Reimbursement Of Leqembi
Sweden's BioArctic Q2 revenue falls despite higher Leqembi royalties
Brief: BioArctic Q2 Net Sales Down At SEK 247.5 Mln